SCNI•benzinga•
Scinai Immunotherapeutics Reports Q1 Revenues Of $586,000; Exits Quarter With Cash & Equivalents Worth $1.01M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 30, 2025 by benzinga